Results 71 to 80 of about 24,084 (145)

SYSTEMIC AMYLOIDOSIS PRESENTING WITH LYMPHADENOPATHY: A DIAGNOSTIC OVERLAP WITH MULTIPLE MYELOMA AND POSSIBLE CARDIAC INVOLVEMENT

Hematology, Transfusion and Cell Therapy
Introduction: Systemic amyloidosis is a condition where amyloid proteins accumulate in organs and tissues, causing multisystem dysfunction. Its presentation often overlaps with other conditions like lymphoproliferative disorders and multiple myeloma (MM).
Naciye Nur Tozluklu, İdil Yürekli, Şule Menziletoğlu Yıldız, Birol Güvenç   +3 more
doaj   +1 more source

Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis

Case Reports in Cardiology, 2018
Cardiac amyloidosis is a rare disease, and its prevalence varies depending on the type of amyloid protein involved. Several case reports make reference to the increased risk of thrombosis and thromboembolic events in cardiac amyloidosis. We report a case
Jan M. Griffin, Daniel P. Judge, Kenton J. Zehr, Jose Madrazo, Rosanne Rouf   +4 more
doaj   +1 more source

Multimodality Imaging in Monoclonal Gammopathy of Undetermined Significance and ATTR Wild-Type Cardiac Amyloidosis

Life
Amyloidosis is characterized by the tissue deposition of insoluble fibrils derived from misfolded proteins. This case report describes a Hispanic man diagnosed with both monoclonal gammopathy of undetermined significance (MGUS) and wild-type ...
Amalia Peix, Aylen Perez, Yrving Figueredo, Leonel Torres, Lazaro O. Cabrera, Giselle Monzon, Hilda Roblejo, Alejandro Perera, Anita Brink, Diana Paez   +9 more
doaj   +1 more source

Cardiac Amyloidosis: A Narrative Review of Diagnostic Advances and Emerging Therapies

Biomedicines
Background/Objectives: Cardiac amyloidosis (CA) is an underdiagnosed and potentially life-threatening infiltrative cardiomyopathy characterized by the extracellular deposition of misfolded amyloid fibrils in cardiac tissue. It is most commonly associated
Dana Emilia Movila, Alexandru Catalin Motofelea, Dragos Cozma, Oana Albai, Alexandra Christa Sima, Minodora Andor, Tudor Ciocarlie, Simona Ruxanda Dragan   +7 more
doaj   +1 more source

Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States

ClinicoEconomics and Outcomes Research, 2019
Tiffany P Quock,1 Tingjian Yan,2 Ryan Tieu,2 Anita D’Souza,3 Michael S Broder21Medical Affairs, Prothena Biosciences Inc, South San Francisco, CA, USA; 2Health Services Research, Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA;
Quock TP, Yan T, Tieu R, D'Souza A, Broder MS   +4 more
doaj  

Cardiac amyloidosis in a Swiss autopsy cohort – distribution and clinical relevance

Swiss Medical Weekly
AIMS: Cardiac amyloidosis (CA) characterised by myocardial amyloid accumulation is likely underdiagnosed. The distribution and extent of myocardial amyloid deposits remain unclear.
Albert Baschong, Sara Ersözlü, Frank Ruschitzka, Andreas J. Flammer, Christoph A. Meier, Zsuzsanna Varga, Holger Moch, Umberto Maccio   +7 more
doaj   +1 more source

True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis

Haematologica, 2018
Avinainder Singh, Hallie I. Geller, Kevin M. Alexander, Robert F. Padera, Richard N. Mitchell, Sharmila Dorbala, Jorge J. Castillo, Rodney H. Falk   +7 more
doaj   +1 more source

A propensity-matched analysis of cardiac operation in patients with and without cardiac amyloidosisCentral MessagePerspective

JTCVS Open
Objective: There are limited data on the outcome of routine cardiac operations in patients with cardiac amyloidosis. This study studied the impact of amyloidosis on early and late results of cardiac operations.
Akshay Chauhan, MBBS, Kevin L. Greason, MD, Daniel D. Borgeson, MD, Austin Todd, MS, John M. Stulak, MD, Richard C. Daly, MD, Juan A. Crestanello, MD, Hartzell V. Schaff, MD   +7 more
doaj   +1 more source

Biomolecular mechanisms of cardiac amyloidosis and its cardiovascular pathological basis. [PDF]

Front Immunol
Zhang L, Jiao Y, Guo J.
europepmc   +1 more source

Outcomes and predictors of atrial fibrillation in cardiac amyloidosis. [PDF]

Medicine (Baltimore)
Rehman WU, Alam I, Shah T, Zahir J, Khan MS, Khalil H, Osama M, Akhtar W, Malik J, Parveen A.   +9 more
europepmc   +1 more source